Indo Borax & Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 21, 2026.
INDOBORAX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 15.8 pts more than Nifty Microcap 250 and 17.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indo Borax & Chemicals reported strong full-year results for FY 2025-26. Standalone revenue grew 23% to ₹21,545.11 lakhs from ₹17,526.11 lakhs, while PAT increased 18.76% to ₹4,973.97 lakhs from ₹4,188.20 lakhs. Consolidated PAT stood at ₹5,026.98 lakhs. The Board recommended a final dividend of ₹10 per share (1000%) and a special dividend of ₹30 per share (3000%), totaling ₹40 per share, subject to shareholder approval at the AGM. The statutory auditors issued an unmodified (clean) opinion with no qualifications. The audit report includes an Emphasis of Matter regarding an Inter Corporate Deposit of ₹5.09 crores given to a party under corporate insolvency resolution under IBC, where the company has filed its claim with NCLT. The company also appointed a new internal auditor and reconstituted its Nomination and Remuneration Committee.
The 23% revenue growth and ~19% PAT growth reflect solid operational performance. The generous dividend payout signals confidence in cash flows. However, investors should note the Emphasis of Matter regarding the ₹5.09 crore ICD exposure under insolvency proceedings, which represents a contingent risk.